Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tobramycin-curare interaction.

P M Waterman, R B Smith

    Anesthesia and Analgesia
    |July 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    A patient experienced muscle weakness after surgery despite anesthesia reversal. Subsequent administration of tobramycin led to recurrent paralysis, successfully treated with prostigmine.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lymphocyte activation during acute simian/human immunodeficiency virus SHIV(89.6PD) infection in macaques.

    Journal of virology·1999
    Same author

    Acute effects of pathogenic simian-human immunodeficiency virus challenge on vaccine-induced cellular and humoral immune responses to Gag in rhesus macaques.

    Journal of virology·1999
    Same author

    Safety, health, and ISO 9000.

    Occupational health & safety (Waco, Tex.)·1995
    Same author

    Carotid artery shortening: a safe adjunct to carotid endarterectomy.

    Journal of vascular surgery·1995
    Same author

    Clinical audit and standardised follow up improve quality of documentation in diabetes care.

    The New Zealand medical journal·1995
    Same author

    Triazolam pharmacokinetics after intravenous, oral, and sublingual administration.

    Journal of clinical psychopharmacology·1995
    Same journal

    Incomplete Recovery of Diaphragmatic Mechanics at a Train-of-Four Ratio of 0.90 to <0.95 Assessed by Dynamic Digital Radiography: A Proof-of-Concept Case Series.

    Anesthesia and analgesia·2026
    Same journal

    Patients' Perspectives and Experiences of Participating in Anesthesia Research: A Qualitative Study.

    Anesthesia and analgesia·2026
    Same journal

    Impact of Epidural-Related Maternal Fever on Neonatal Outcomes: A Single-Center Retrospective Case-Control Study Excluding Confirmed Histological Chorioamnionitis.

    Anesthesia and analgesia·2026
    Same journal

    Patient Beliefs and Experiences of Adhering to Medical Therapies for Cardiovascular Comorbidities, Before Noncardiac Elective Surgery in South Africa: A Mixed-Methods Study.

    Anesthesia and analgesia·2026
    Same journal

    Beyond Administrative Indices: Allostatic Load and Autonomic Dyshomeostasis as Biological Mediators of Intraoperative Cardiac Arrest.

    Anesthesia and analgesia·2026
    Same journal

    In Response.

    Anesthesia and analgesia·2026
    See all related articles

    Area of Science:

    • Anesthesiology
    • Pharmacology
    • Critical Care Medicine

    Background:

    • Neuromuscular blocking agents are crucial for surgical procedures.
    • Prostigmine is a standard reversal agent for neuromuscular blockade.
    • Postoperative monitoring is essential for detecting adverse events.

    Observation:

    • A 59-year-old patient underwent urologic surgery with d-tubocurarine-fentanyl-N2O anesthesia.
    • Neuromuscular blockade was initially reversed with prostigmine post-surgery.
    • The patient developed recurrent paralysis after intravenous tobramycin administration.

    Findings:

    • Recurarization occurred despite initial successful reversal of neuromuscular blockade.
    • Prostigmine was effective in reversing the tobramycin-induced neuromuscular blockade.

    Related Experiment Videos

  • This suggests a potential interaction between tobramycin and neuromuscular blocking agents.

    • Implications:

    • Clinicians should be aware of the potential for tobramycin to induce or exacerbate neuromuscular blockade.
    • Careful patient monitoring is warranted after tobramycin administration in patients with recent neuromuscular blockade.
    • Further research may be needed to elucidate the mechanism of tobramycin-induced neuromuscular dysfunction.